(Q45060352)

English

Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

0 references

Terese L Katzenstein

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

object named as

Obel N

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

9

object named as

Lundgren JD

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

object named as

Kirk O

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Røge BT

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Barfod TS

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Nielsen H

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Pedersen C

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Mathiesen LR

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Gerstoft J

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

344-351

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2004.00233.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2004.00233.X

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45060352&oldid=2064348373"